Peter Anderson, PharmD

Skaggs School of Pharmacy and Pharmaceutical Sciences / University of Colorado Anschutz Medical Campus

Disclosure(s): Gilead: Grant/Research Support

Poster(s):

• (P-1222) Oral Cephalexin Population Pharmacokinetics and Target Attainment Analysis in Infants 0-60 Days Old
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT